Riskpilot← Back to searchSign inGet full accessDr Josefsson AB
ABActiveOrg 5568449887Ingemarsgatan 2 3trBusiness and other management consultancy activities · NACE 7020Est. 20110 employees
Revenue 2025
SEK 247K
-51% vs 2024
EBITDA margin
17.4%
-83% vs 2024
Equity ratio
85.8%
Financial strength
Net profit 2025
SEK -1K
-101% vs 2024
| Revenue | SEK 247K | -51% |
| EBITDA | SEK 43K | -83% |
| Net profit | SEK -1K | -101% |
| Total assets | SEK 339K | -43% |
| Equity | SEK 290K | -34% |
| Employees | 0 | — |
Legal name
Dr Josefsson AB
Org number
5568449887
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
8 mars 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinskt arbete, hälsointyg och konsultation inom medicinala frågor, utbildning och forskning samt föreläsning inom medicin och företag samt dithörande verksamhet inom företag, även patientvård.
Address
Ingemarsgatan 2 3tr
Email
dr.josefsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 388 | 280 | 293 | 499 | 247 |
| Staff expenses | — | −53 | −45 | −64 | −50 |
| EBITDA | 29 | 15 | −8 | 256 | 43 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 29 | 15 | −8 | 256 | 43 |
| Net financials | — | 0 | 1 | 1 | −39 |
| Profit before tax | −81 | 15 | −7 | 256 | 4 |
| Tax | −0 | — | — | −41 | −5 |
| Net profit | −81 | 15 | −7 | 215 | −1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 491 | 325 | 319 | 590 | 339 |
| Equity | 269 | 283 | 276 | 442 | 290 |
| Long-term debt | 2 | 1 | 1 | 1 | 0 |
| Short-term debt | 221 | 41 | 42 | 147 | 48 |
| Total debt | 223 | 41 | 43 | 148 | 48 |
EBITDA margin
17.4%
This company
15.8%
Market median
+10% vs market
20212025
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
20212025
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20212025
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212025
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Josefsson AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Kristina Josefsson Westman | Deputy Board Member | 0 companies |
| Leif Nicklas Josefsson | Board of Directors | 0 companies |
| Edwina Mirjam Iris Laura Ellen Larkman | Deputy Board Member | 0 companies |